The evidence for ketamine treatment in older adults with psychiatric illness: a scoping review
Background: Ketamine, an N-methyl-D-aspartate antagonist, has been used for decades as an anesthetic agent, but more recently it has been studied in psychiatric illness. Though ketamine has been investigated for use in the general population, fewer studies have investigated the efficacy and tolerabi...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publishing
2025-10-01
|
| シリーズ: | Therapeutic Advances in Chronic Disease |
| オンライン･アクセス: | https://doi.org/10.1177/20406223251384803 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|